A Cohort Study of Anticholinergic Medication Burden and Incident Dementia and Stroke in Older Adults

Background Anticholinergic medications may increase risk of dementia and stroke, but prospective studies in healthy older people are lacking. Objective Compare risk of incident dementia and stroke by anticholinergic burden among initially healthy older people. Design Prospective cohort study. Setting Primary care (Australia and USA). Participants 19,114 community-dwelling participants recruited for the ASPREE trial, aged 70+ years (65+ if US minorities) without major cardiovascular disease, dementia diagnosis, or Modified Mini-Mental State Examination score below 78/100. Measurements Baseline anticholinergic exposure was calculated using the Anticholinergic Cognitive Burden (ACB) score. Dementia was adjudicated using Diagnostic and Statistical Manual of Mental Disorders volume IV criteria, and stroke using the World Health Organization definition. Results At baseline, 15,000 participants (79%) had an ACB score of zero, 2930 (15%) a score of 1-2, and 1184 (6%) a score of >= 3 (indicating higher burden). After a median follow-up of 4.7 years and adjusting for baseline covariates, a baseline ACB score of >= 3 was associated with increased risk of ischemic stroke (adjusted HR 1.58, 95% CI 1.06, 2.35), or dementia (adjusted HR 1.36, 95% CI 1.01, 1.82), especially of mixed etiology (adjusted HR 1.53, 95% CI 1.06, 2.21). Results were similar for those exposed to moderate/highly anticholinergic medications. Limitations Residual confounding and reverse causality are possible. Assessment of dose or duration was not possible. Conclusions High anticholinergic burden in initially healthy older people was associated with increased risk of incident dementia and ischemic stroke. A vascular effect may underlie this association. These findings highlight the importance of minimizing anticholinergic exposure in healthy older people.

Automated summary

The study suggests that high anticholinergic burden in initially healthy older people is associated with an increased risk of incident dementia and ischemic stroke, especially of mixed etiology dementia. Therefore, it is important to minimize anticholinergic exposure in healthy older people to reduce the risk.